Position in PCVX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,416,464
-$1,030,911 QoQ
Shares Held
41,570
-29.9% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#127
of 329 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $556,047,667 across 189 Biotechnology names. PCVX ranks #46 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in PCVX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,416,464 | 41,570 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,447,375 | 59,325 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $757,849 | 16,425 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $701,165 | 19,466 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,371,002 | 134,451 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,773,468 | 126,416 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $10,459,334 | 127,771 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $11,044,537 | 96,653 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,141,832 | 81,338 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,746,188 | 54,841 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,292,890 | 36,511 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,848,942 | 36,268 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,022,763 | 120,600 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,582,292 | 42,217 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,983,403 | 41,364 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $346,344 | 14,431 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $308,252 | 14,166 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $235,996 | 9,920 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||